Labstyle Innovations Corp is an Israel-based developer of the Dario diabetes management solution. It is engaged in developing and commercializing patent-pending technology that is seeking to bring clinical laboratory testing capabilities to consumers through the use of smartphones. The Company’s initial product is Dario, which is a device and software system for patient self-monitoring of blood glucose (SMBG). Dario is a patent pending system, which combines an all-in-one SMBG device consisting of a lancet to obtain a blood sample, a device-specific disposable test strip cartridge and a smartphone driven glucose reader adaptor to hold the strip and interface with the smartphone, coupled with a smartphone application and Internet-based data services. Dario will offer millions of diabetics, and in particular insulin dependent diabetics, a new option to the SMBG test kits.